Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Public ClinicalTrials.gov record NCT00359632. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Study identification
- NCT ID
- NCT00359632
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 34 participants
Conditions and interventions
Conditions
Interventions
- Matched control Drug
- Zyvox - linezolid Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2008
- Primary completion
- Nov 30, 2013
- Completion
- Nov 30, 2013
- Last update posted
- Jun 25, 2015
2008 – 2013
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Bernards Research Center | Jonesboro | Arkansas | 72401 | — |
| Triple O Research Institute, PA | West Palm Beach | Florida | 33401 | — |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| University of Minnesota, Department of Medicine/Division of Infectious Diseases | Minneapolis | Minnesota | 55455 | — |
| Drexel University College of Medicine, Partnership Comprehensive Care Practice | Philadelphia | Pennsylvania | 19102 | — |
| Associates in Infectious Disease and Tropical Medicine | Pittsburgh | Pennsylvania | 15206 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00359632, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 25, 2015 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00359632 live on ClinicalTrials.gov.